Is Compounded tirzepatide or Foundayo better for weight loss?

Only Foundayo has a trial figure recorded here: 11.1% average weight loss, from its own label trial. Compounded tirzepatide has none on this site — a compounded preparation has no trial of its own, so the two cannot be compared on effect and this page does not pick one on it.

Can you switch between Compounded tirzepatide and Foundayo?

They are different molecules, so this is a change of medication rather than of brand, and the one you move to is started on its own dosing schedule.

← All providers and medications

Compounded tirzepatide vs Foundayo (orforglipron)

Verdict

Foundayo is the better choice of the two, winning on entry price, regulatory and complaint risk and approved product or compounded copy (halfrx score 6.3 against 1.8).

Computed from the stored fields, so it moves when a price does. Nothing here is written by hand or by a model.

Which is cheaper, Compounded tirzepatide or Foundayo (orforglipron)?

Compounded tirzepatide is $199–$359 a month all-in, the range its sellers here charge, oldest read 2026-09-13; Foundayo (orforglipron) is $149–$349, read from its own page on 2026-09-12. Every axis below is computed from stored fields rather than written by hand, so the comparison moves when a price does. They were last checked on 2026-09-13 and 2026-09-12. Flags recorded here: Compounded tirzepatide — not FDA approved, manufacturer lawsuit, supply risk. Foundayo (orforglipron) is an FDA-approved product and Compounded tirzepatide is a compounded copy made under the pharmacy-compounding exemption, which is a legal status rather than a quality claim. The published formula scores them 1.8 and 6.3 out of 10, arithmetic over the same stored fields rather than an editor's preference. Cost here is scored on what a patient pays once titrated, never on the entry price, because an introductory rate covers the months before anybody has reached the dose they stay on.

Head to head

Compounded tirzepatide against Foundayo (orforglipron), one row per axis, with the side that wins each axis marked.
What decides it	Compounded tirzepatide $199–$359/mo	Foundayo $149–$349/mo
Entry priceFoundayo (orforglipron) is $50/mo cheaper to start — $149 against $199.	—	✓ better here
Regulatory and complaint riskCompounded tirzepatide: 3 serious flags. Foundayo (orforglipron): none.	—	✓ better here
Approved product or compounded copyFoundayo (orforglipron) supplies an FDA-approved product; Compounded tirzepatide supplies a compounded preparation, which the FDA does not review for safety, efficacy or quality and which can stop shipping if its pharmacy is enjoined.	—	✓ better here

Compounded tirzepatide publishes no page halfrx will send you toGo to Foundayo ↗

What separates these two, price aside

These are different molecules — tirzepatide against orforglipron — so this is a comparison of two treatments, not of two prices for one.

503A/503B compounding pharmacies

Compounded tirzepatide

1.8

$199–$359/mo all-in

checked 2026-09-13 — no maintenance-dose price

Not FDA approvedCompounding legal riskManufacturer lawsuitSupply risk

Eli Lilly

Foundayo (orforglipron)

6.3

$149–$349/mo all-in

verified 2026-09-12

Newly approvedPrice conditional on refill timingBoxed warning

Compounded tirzepatide

Pros

+Access to tirzepatide, the most effective molecule, at $199–$359/mo against Zepbound's $1,086 list.[1]
+Vial dosing allows finer titration than branded pens.[1]

Cons

−Not FDA approved — no review of safety, efficacy or manufacturing quality.[1]
−Eli Lilly has active lawsuits against compounded tirzepatide sellers, including Henry Meds. A ruling against your provider ends your supply.[2]
−The tirzepatide shortage that legally permitted mass compounding has been resolved, so the category now operates on contested legal ground.[2]
−Zepbound vials through LillyDirect start at $299/mo — the branded gap is far smaller than it was, which weakens the only argument for compounding.[1]

Sources

Foundayo (orforglipron)

Pros

+A daily pill with no injection, no needles and no refrigeration — unlike semaglutide pills it is a small molecule, so there are no food-and-water timing rules to follow.[3]
+$149 a month at the entry dose through LillyDirect — the lowest self-pay price for a branded GLP-1 on this site, matched only by the Wegovy pill's first month.[4]
+11.1% mean weight loss over 72 weeks in ATTAIN-1, intention-to-treat — below the Wegovy tablet's 13.6%, and well above the older oral options.[2]
+Being a small molecule, it is manufactured chemically rather than biologically — supply scales in a way peptide injectables cannot.[3]
+Commercially insured with coverage, Lilly's card can bring it to as little as $25 a month.[1]

Cons

−Approved 1 April 2026, so real-world safety data outside trials is still thin compared with semaglutide's years of use.[2]
−$649 list price if you have no coverage and do not use the LillyDirect self-pay channel.[4]
−Weight loss trails tirzepatide injection, which reaches roughly 20%+ in its pivotal trials.[2]
−Maintenance doses hold their $299 price only while you refill within 45 days; lapse and they are $349.[1]

Sources

Foundayo side effects →Foundayo dosage →

Comparisons are computed from the fields on each card, not written by hand or by a model, so they change when the data does. Information only, not medical advice. halfrx may earn a commission from some links, which never changes what a comparison says.

Everything on Compounded tirzepatide

Everything on Foundayo

The registers and documents behind both sides

Two cards compared on the same checks. These are the registers those checks were run against, and the FDA's own pages where either side is a compounded product.

Compounding and the FDA: questions and answers — What a compounded drug is, and what the FDA does and does not review before it is sold.
Medications containing semaglutide marketed for type 2 diabetes or weight loss, FDA — The FDA's own notice on compounded semaglutide and what it has not evaluated.

Compounded tirzepatide against Foundayo, answered

Is Compounded tirzepatide or Foundayo better for weight loss?: Only Foundayo has a trial figure recorded here: 11.1% average weight loss, from its own label trial. Compounded tirzepatide has none on this site — a compounded preparation has no trial of its own, so the two cannot be compared on effect and this page does not pick one on it.
Which is cheaper, Compounded tirzepatide or Foundayo?: Foundayo starts lower, at $149 a month against $199. For Compounded tirzepatide ($199–$359) only a starting price is published, not one for the maintenance dose, so which costs less once titrated cannot be worked out here.
Can you switch between Compounded tirzepatide and Foundayo?: They are different molecules, so this is a change of medication rather than of brand, and the one you move to is started on its own dosing schedule.